The global exoskeleton market size was estimated at USD 498.33 million in 2024 and is projected to reach USD 1.25 billion by 2030, growing at a CAGR of 16.27% from 2025 to 2030. Several major factors are driving this significant growth. A rapidly expanding global geriatric population is contributing to a rising need for assistive mobility devices. Additionally, the adoption of advanced medical technologies across diverse industries—such as automotive, military, defense, and construction—is further propelling the demand for exoskeletons. Moreover, the increasing incidence of stroke, which often results in long-term mobility impairments, is another key factor supporting market growth.

Another major contributor to this rising demand is the growing number of spinal cord injury (SCI) cases worldwide. For example, data from the National Spinal Cord Injury Statistical Center (NSCISC) shows that in the United States alone, around 17,730 new cases of spinal cord injuries are reported each year, and approximately 291,000 individuals are currently living with these conditions. Such statistics underscore the urgent need for effective rehabilitation technologies. Exoskeleton systems are being increasingly adopted not only in medical applications but also across industrial sectors to promote worker health, reduce fatigue, and enhance operational productivity.

This surge in demand has also encouraged the emergence of several startups specializing in exoskeleton technologies. These companies are focusing on delivering innovative rehabilitation solutions tailored to patients with mobility challenges. As the exoskeleton industry continues to evolve, market players are consistently engaged in research and development to create advanced products that meet the growing needs of users. One notable example is Ekso Bionics, which in June 2022 received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market its EksoNR robotic exoskeleton. This next-generation device is specifically designed to support the rehabilitation of patients with multiple sclerosis, further expanding the clinical applications of exoskeleton technology.

The rising global prevalence of spinal cord injuries continues to be a key factor accelerating the growth of the exoskeleton market. Patients suffering from such injuries are increasingly being recommended exoskeletons as part of their recovery and mobility improvement plans. This trend has led to a surge in adoption among both patients and healthcare providers. According to the World Health Organization (WHO), an estimated 250,000 to 500,000 individuals worldwide suffer spinal cord injuries each year. This growing patient population is directly contributing to the increased use of exoskeletons for rehabilitation and mobility support.

Key Market Trends & Insights:

• In 2024, North America emerged as the leading region in the global exoskeleton market, accounting for a substantial 45.13% share of the total market revenue and 26.32% of the overall volume. This strong regional performance is largely attributed to advanced healthcare infrastructure, a high rate of adoption of cutting-edge medical technologies, and supportive government initiatives promoting rehabilitation and assistive technologies. Within North America, the United States held the dominant position, further solidifying the region’s leadership in the global market. The U.S. has been at the forefront of exoskeleton development and implementation, driven by continuous innovation, strong research and development activities, and a growing number of clinical applications.

• Looking ahead, the Asia Pacific region is expected to experience the fastest growth during the forecast period. Factors contributing to this rapid expansion include a rising geriatric population, increasing awareness of rehabilitation technologies, government investments in healthcare advancements, and a growing incidence of mobility-related disorders.

• When analyzed by mobility type, the mobile exoskeleton segment led the market in 2024, capturing the highest revenue share of 62.39%. This dominance reflects the increasing preference for wearable and portable exoskeleton systems, particularly those designed to assist individuals in walking and performing daily activities independently.

• From the perspective of extremity, the lower body segment held the largest revenue share in the global exoskeleton market. This is primarily due to the high demand for lower body exoskeletons in rehabilitation centers and hospitals, especially for patients with lower limb disabilities, spinal cord injuries, and neurological conditions affecting mobility.

Order a free sample PDF of the Exoskeleton Market Intelligence Study, published by Grand View Research.

Market Size & Forecast:

• 2024 Market Size: USD 498.33 Million

• 2030 Projected Market Size: USD 1.25 Billion

• CAGR (2025-2030): 16.27%

• North America: Largest market in 2024

• Asia Pacific: Fastest growing market

Key Companies & Market Share Insights:

The exoskeleton market is predominantly led by key players that emphasize continuous innovation, advanced product development, and strategic partnerships to sustain and strengthen their competitive positions. These companies invest heavily in research and development to bring cutting-edge solutions to market, enabling them to stay ahead in an increasingly competitive landscape.

A notable example of such innovation occurred in March 2023, when Svaya Robotics introduced both a quadruped robot and a wearable exoskeleton. The exoskeleton was uniquely engineered to align with the physical structure of Indian soldiers. It is designed to enhance their physical capabilities by enabling them to walk long distances with less fatigue and carry heavy loads with significantly reduced effort. This development reflects the growing trend of tailoring exoskeleton technologies for specific use cases, such as military applications, where endurance and load-bearing capacity are critical.

Market dominance is primarily concentrated among well-established players who possess robust financial and technical resources, allowing them to invest in large-scale research initiatives and advanced manufacturing processes. These companies often lead the industry in innovation and global outreach. At the same time, a growing number of emerging players are making their presence felt by focusing on cost-effective product offerings and pushing the boundaries of technology. These newer entrants often bring agility and fresh perspectives to the market, especially in areas like lightweight designs, modular systems, and affordability—targeting sectors or regions with budget constraints or specific functional needs.

Key Players

• Ekso Bionics

• ARMASTEC PTE. LTD

• Hocoma

• Lockheed Martin Corporation

• Suit X

• Rex Bionics Plc.

• RB3D

• ReWalk Robotics

• Cyberdyne, Inc.

• ActiveLink (Panasonic Corporation)

• DIH Medical

Explore Horizon Databook – The world's most expansive market intelligence platform developed by Grand View Research.

Conclusion:

The exoskeleton market is expanding rapidly, driven by aging populations, growing demand in healthcare and industrial applications, and advancements in AI-enhanced, mobile wearable designs. Key industry leaders are advancing through innovation, strategic collaborations, and broader insurance coverage, while developing countries are emerging as high-growth regions due to increased healthcare infrastructure and rehabilitation needs.